These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
149 related items for PubMed ID: 24078348
1. An analysis of polymorphisms within the Wnt signaling pathway in relation to ovarian cancer risk in a Polish population. Mostowska A, Pawlik P, Sajdak S, Markowska J, Pawałowska M, Lianeri M, Jagodzinski PP. Mol Diagn Ther; 2014 Feb; 18(1):85-91. PubMed ID: 24078348 [Abstract] [Full Text] [Related]
3. Polymorphic variants in the vitamin D pathway genes and the risk of ovarian cancer among non-carriers of BRCA1/BRCA2 mutations. Mostowska A, Sajdak S, Pawlik P, Lianeri M, Jagodzinski PP. Oncol Lett; 2016 Feb; 11(2):1181-1188. PubMed ID: 26893716 [Abstract] [Full Text] [Related]
5. Genetic testing in Poland and Ukraine: should comprehensive germline testing of BRCA1 and BRCA2 be recommended for women with breast and ovarian cancer? Nguyen-Dumont T, Karpinski P, Sasiadek MM, Akopyan H, Steen JA, Theys D, Hammet F, Tsimiklis H, Park DJ, Pope BJ, Slezak R, Stembalska A, Pesz K, Kitsera N, Siekierzynska A, Southey MC, Myszka A. Genet Res (Camb); 2020 Aug 10; 102():e6. PubMed ID: 32772980 [Abstract] [Full Text] [Related]
6. Large BRCA1 and BRCA2 genomic rearrangements in Polish high-risk breast and ovarian cancer families. Rudnicka H, Debniak T, Cybulski C, Huzarski T, Gronwald J, Lubinski J, Gorski B. Mol Biol Rep; 2013 Dec 10; 40(12):6619-23. PubMed ID: 24065545 [Abstract] [Full Text] [Related]
7. Selected Aspects of Molecular Diagnostics of Constitutional Alterations in BRCA1 and BRCA2 Genes Associated with Increased Risk of Breast Cancer in the Polish Population. Górski B. Hered Cancer Clin Pract; 2006 Aug 15; 4(3):142-52. PubMed ID: 20223018 [Abstract] [Full Text] [Related]
8. New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing. Kluska A, Balabas A, Paziewska A, Kulecka M, Nowakowska D, Mikula M, Ostrowski J. BMC Med Genomics; 2015 May 07; 8():19. PubMed ID: 25948282 [Abstract] [Full Text] [Related]
10. Double mutation of APC and BRCA1 in an Italian family. Vietri MT, D'Elia G, Caliendo G, Casamassimi A, Resse M, Passariello L, Cioffi M, Molinari AM. Cancer Genet; 2020 Jun 07; 244():32-35. PubMed ID: 32388397 [Abstract] [Full Text] [Related]
12. Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers. Kotsopoulos J, Lubinski J, Gronwald J, Cybulski C, Demsky R, Neuhausen SL, Kim-Sing C, Tung N, Friedman S, Senter L, Weitzel J, Karlan B, Moller P, Sun P, Narod SA, Hereditary Breast Cancer Clinical Study Group. Int J Cancer; 2015 Sep 01; 137(5):1136-46. PubMed ID: 25482078 [Abstract] [Full Text] [Related]
13. BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families. Cherbal F, Bakour R, Adane S, Boualga K, Benais-Pont G, Maillet P. Dis Markers; 2010 Sep 01; 28(6):377-84. PubMed ID: 20683152 [Abstract] [Full Text] [Related]
14. Frequency and spectrum of founder and non-founder BRCA1 and BRCA2 mutations in a large series of Russian breast cancer and ovarian cancer patients. Sokolenko AP, Sokolova TN, Ni VI, Preobrazhenskaya EV, Iyevleva AG, Aleksakhina SN, Romanko AA, Bessonov AA, Gorodnova TV, Anisimova EI, Savonevich EL, Bizin IV, Stepanov IA, Krivorotko PV, Berlev IV, Belyaev AM, Togo AV, Imyanitov EN. Breast Cancer Res Treat; 2020 Nov 01; 184(1):229-235. PubMed ID: 32776218 [Abstract] [Full Text] [Related]
15. A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers. Wang WW, Spurdle AB, Kolachana P, Bove B, Modan B, Ebbers SM, Suthers G, Tucker MA, Kaufman DJ, Doody MM, Tarone RE, Daly M, Levavi H, Pierce H, Chetrit A, Yechezkel GH, Chenevix-Trench G, Offit K, Godwin AK, Struewing JP. Cancer Epidemiol Biomarkers Prev; 2001 Sep 01; 10(9):955-60. PubMed ID: 11535547 [Abstract] [Full Text] [Related]
16. Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study. McLaughlin JR, Risch HA, Lubinski J, Moller P, Ghadirian P, Lynch H, Karlan B, Fishman D, Rosen B, Neuhausen SL, Offit K, Kauff N, Domchek S, Tung N, Friedman E, Foulkes W, Sun P, Narod SA, Hereditary Ovarian Cancer Clinical Study Group. Lancet Oncol; 2007 Jan 01; 8(1):26-34. PubMed ID: 17196508 [Abstract] [Full Text] [Related]
17. Rapid and easy detection of the five most common mutations in BRCA1 and BRCA2 genes in the Polish population using CAPS and ACRS-PCR methods. Dąbrowski A, Ułaszewski S, Niedźwiecka K. Acta Biochim Pol; 2019 Feb 06; 66(1):33-37. PubMed ID: 30726305 [Abstract] [Full Text] [Related]
18. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Satagopan JM, Boyd J, Kauff ND, Robson M, Scheuer L, Narod S, Offit K. Clin Cancer Res; 2002 Dec 06; 8(12):3776-81. PubMed ID: 12473589 [Abstract] [Full Text] [Related]
19. MDM2 SNP309 accelerates breast and ovarian carcinogenesis in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent. Yarden RI, Friedman E, Metsuyanim S, Olender T, Ben-Asher E, Papa MZ. Breast Cancer Res Treat; 2008 Oct 06; 111(3):497-504. PubMed ID: 18026875 [Abstract] [Full Text] [Related]
20. BRCA1 founder mutations do not contribute to increased risk of gastric cancer in the Polish population. Ławniczak M, Jakubowska A, Białek A, Lubiński J, Jaworska-Bieniek K, Kaczmarek K, Starzyńska T. Hered Cancer Clin Pract; 2016 Oct 06; 14():3. PubMed ID: 26779294 [Abstract] [Full Text] [Related] Page: [Next] [New Search]